Skip to main content
Erschienen in: Cancer Causes & Control 5/2013

01.05.2013 | Original paper

An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996–2009

verfasst von: Paramita Dasgupta, Danny R. Youlden, Peter D. Baade

Erschienen in: Cancer Causes & Control | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Colorectal cancer survivors are at risk of dying from other causes including comorbidities and second malignancies. This study was undertaken to identify demographic and clinical predictors of cancer-specific and competing causes of mortality.

Methods

The crude probabilities of mortality attributed to colorectal cancer, other cancers, and non-cancer causes were estimated for 19,415 residents of Queensland, Australia, who were diagnosed with a first primary colorectal cancer between 1996 and 2007 when aged 20–79 years and survived at least 2 months, with follow-up to the end of 2009. Multivariate competing risk analysis was used to analyze covariate effects on the cumulative probability of the different mortality types.

Results

Five-year cumulative probabilities of colorectal cancer, other cancers, and non-cancer mortality were 29.4 % (95 % CI 29.3, 30.7), 2.0 % (95 % CI 1.8, 2.2), and 5.7 % (95 % CI 5.3, 6.0), respectively. Factors associated with an increased risk of non-cancer mortality included older age, male gender, unmarried status, localized disease, first primary colon cancers, no surgery, and the presence of comorbidities. Apart from diagnosis of a metachronous secondary cancer, being older, unmarried, or in blue-collar occupations were independent predictors of increased mortality due to other cancers.

Conclusions

A better understanding of the role of competing events and the ability to predict risk of such events have the potential to translate into more effective individualized strategies for colorectal cancer management. The control of comorbidities and reducing cancer risk through clinical management and lifestyle changes should be an important and attainable goal for CRC survivors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gellad ZF, Provenzale D (2010) Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 138:2177–2190PubMedCrossRef Gellad ZF, Provenzale D (2010) Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 138:2177–2190PubMedCrossRef
2.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008: Cancer incidence and mortality worldwide. IARC, Lyon. Available from: http://globcan.iarc.fr/. Accessed 20 May 2011 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008: Cancer incidence and mortality worldwide. IARC, Lyon. Available from: http://​globcan.​iarc.​fr/​. Accessed 20 May 2011
3.
4.
Zurück zum Zitat Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 16:566–571PubMedCrossRef Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 16:566–571PubMedCrossRef
5.
Zurück zum Zitat Campo RA, Rowland JH, Irwin ML, Nathan PC, Gritz ER, Kinney AY. (2011) Cancer prevention after cancer: changing the paradigm—a report from the American society of preventive oncology. Cancer Epidemiol Biomarkers Prev Campo RA, Rowland JH, Irwin ML, Nathan PC, Gritz ER, Kinney AY. (2011) Cancer prevention after cancer: changing the paradigm—a report from the American society of preventive oncology. Cancer Epidemiol Biomarkers Prev
7.
Zurück zum Zitat Dasgupta P, Youlden DY, Baade PD (2012) Multiple primary cancers among colorectal cancer survivors in Queensland, Australia, 1996–2007. Cancer Causes Control 23:1387–1398PubMedCrossRef Dasgupta P, Youlden DY, Baade PD (2012) Multiple primary cancers among colorectal cancer survivors in Queensland, Australia, 1996–2007. Cancer Causes Control 23:1387–1398PubMedCrossRef
8.
Zurück zum Zitat Zamboni BA, Yothers G, Choi M et al (2010) Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. J Clin Oncol 28:2544–2548PubMedCrossRef Zamboni BA, Yothers G, Choi M et al (2010) Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. J Clin Oncol 28:2544–2548PubMedCrossRef
9.
Zurück zum Zitat Lee WS, Lee JN, Choi S, Jung M, Baek JH, Lee WK (2010) Multiple primary malignancies involving colorectal cancer-clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg 395:359–364PubMedCrossRef Lee WS, Lee JN, Choi S, Jung M, Baek JH, Lee WK (2010) Multiple primary malignancies involving colorectal cancer-clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg 395:359–364PubMedCrossRef
10.
Zurück zum Zitat Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41:861–870PubMedCrossRef Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41:861–870PubMedCrossRef
11.
Zurück zum Zitat Dignam JJ, Zhang Q, Kocherginsky M (2012) The use and interpretation of competing risks regression models. Clin Cancer Res 18:2301–2308PubMedCrossRef Dignam JJ, Zhang Q, Kocherginsky M (2012) The use and interpretation of competing risks regression models. Clin Cancer Res 18:2301–2308PubMedCrossRef
12.
Zurück zum Zitat Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706PubMedCrossRef Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706PubMedCrossRef
13.
Zurück zum Zitat Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef
14.
Zurück zum Zitat Hanrahan EO, Gonzalez-Angulo AM, Giordano SH et al (2007) Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast Carcinoma. J Clin Oncol 25:4952–4960PubMedCrossRef Hanrahan EO, Gonzalez-Angulo AM, Giordano SH et al (2007) Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast Carcinoma. J Clin Oncol 25:4952–4960PubMedCrossRef
15.
Zurück zum Zitat Mell LK, Dignam JJ, Salama JK et al (2010) Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15–20PubMedCrossRef Mell LK, Dignam JJ, Salama JK et al (2010) Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15–20PubMedCrossRef
16.
Zurück zum Zitat Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK (2011) Population-based study of competing mortality in head and neck cancer. J Clin Oncol 29:3503–3509PubMedCrossRef Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK (2011) Population-based study of competing mortality in head and neck cancer. J Clin Oncol 29:3503–3509PubMedCrossRef
17.
Zurück zum Zitat Pintile M (2006) Competing risks: a practical perspective. Wiley, New yorkCrossRef Pintile M (2006) Competing risks: a practical perspective. Wiley, New yorkCrossRef
19.
Zurück zum Zitat Queensland Cancer Registry, Cancer Council Queensland (2011) Cancer in Queensland: incidence, mortality, survival and prevalence, 1982 to 2008 Queensland Cancer Registry, Cancer Council Queensland (2011) Cancer in Queensland: incidence, mortality, survival and prevalence, 1982 to 2008
20.
Zurück zum Zitat Grulich AE, Swerdlow AJ, Silva IDS, Beral V (1995) Is the apparent rise in cancer mortality in the elderly real? analysis of changes in certification and coding of cause of death in England and Wales, 1970–1990. Int J Cancer 63:164–168PubMedCrossRef Grulich AE, Swerdlow AJ, Silva IDS, Beral V (1995) Is the apparent rise in cancer mortality in the elderly real? analysis of changes in certification and coding of cause of death in England and Wales, 1970–1990. Int J Cancer 63:164–168PubMedCrossRef
21.
Zurück zum Zitat International Agency for Research on Cancer, International Association of Cancer Registries, European Network of Cancer Regstries (2005) International rules for multiple primary cancers. Asian Pac J Cancer Prev 6:104–106 International Agency for Research on Cancer, International Association of Cancer Registries, European Network of Cancer Regstries (2005) International rules for multiple primary cancers. Asian Pac J Cancer Prev 6:104–106
22.
Zurück zum Zitat National Centre for Classification in Health (NCCH). (2006) International statistical classification of diseases and related health problems, 10th revision, Australian Modification (ICD-10-AM). 5th ed. Faculty of Health Sciences, University of Sydney, Sydney National Centre for Classification in Health (NCCH). (2006) International statistical classification of diseases and related health problems, 10th revision, Australian Modification (ICD-10-AM). 5th ed. Faculty of Health Sciences, University of Sydney, Sydney
23.
Zurück zum Zitat Krnjacki LJ, Baade PD, Lynch BM, Aitken JF (2008) Reliability of collecting colorectal cancer stage information from pathology reports and general practitioners in Queensland. Aust N Z J Publ Health 32:378–382CrossRef Krnjacki LJ, Baade PD, Lynch BM, Aitken JF (2008) Reliability of collecting colorectal cancer stage information from pathology reports and general practitioners in Queensland. Aust N Z J Publ Health 32:378–382CrossRef
24.
Zurück zum Zitat Baade PD, Dasgupta P, Aitken JF, Turrell G (2011) Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland. Med J Aust 195:350–354PubMedCrossRef Baade PD, Dasgupta P, Aitken JF, Turrell G (2011) Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland. Med J Aust 195:350–354PubMedCrossRef
25.
Zurück zum Zitat Cramb SM, Garvey G, Valery PC, Williamson JD, Baade PD (2012) The first year counts: cancer survival among Indigenous and non-Indigenous Queenslanders, 1997–2006. Med J Aust 196:270–274PubMedCrossRef Cramb SM, Garvey G, Valery PC, Williamson JD, Baade PD (2012) The first year counts: cancer survival among Indigenous and non-Indigenous Queenslanders, 1997–2006. Med J Aust 196:270–274PubMedCrossRef
26.
Zurück zum Zitat Coviello V, Boggess M (2004) Cumulative incidence estimation in the presence of competing risks. Stat J 4:103–112 Coviello V, Boggess M (2004) Cumulative incidence estimation in the presence of competing risks. Stat J 4:103–112
27.
Zurück zum Zitat Pepe MS, Mori M (1993) Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737–751PubMedCrossRef Pepe MS, Mori M (1993) Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737–751PubMedCrossRef
28.
Zurück zum Zitat Wolbers M, Koller MT, Witteman JC, Steyerberg EW (2009) Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20:555–561PubMedCrossRef Wolbers M, Koller MT, Witteman JC, Steyerberg EW (2009) Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20:555–561PubMedCrossRef
29.
Zurück zum Zitat Kim HT (2007) Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 13:559–565PubMedCrossRef Kim HT (2007) Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 13:559–565PubMedCrossRef
30.
Zurück zum Zitat Cleves MA, Gutierrez RG, Gould MW, Marchenko YV (2010) An introduction to survival analysis using Stata, 3 (Revised ed) edn. Stata Press, College Station Cleves MA, Gutierrez RG, Gould MW, Marchenko YV (2010) An introduction to survival analysis using Stata, 3 (Revised ed) edn. Stata Press, College Station
31.
Zurück zum Zitat Lee M, Cronin KA, Gail MH, Feuer EJ (2012) Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data. Stat Med 31:489–500PubMedCrossRef Lee M, Cronin KA, Gail MH, Feuer EJ (2012) Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data. Stat Med 31:489–500PubMedCrossRef
32.
Zurück zum Zitat Koo JH, Leong RW (2010) Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 25:33–42PubMedCrossRef Koo JH, Leong RW (2010) Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 25:33–42PubMedCrossRef
33.
Zurück zum Zitat Pal SK, Hurria A (2010) Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 28:4086–4093PubMedCrossRef Pal SK, Hurria A (2010) Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 28:4086–4093PubMedCrossRef
35.
Zurück zum Zitat Pinquart M, Duberstein PR (2010) Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 75:122–137PubMedCrossRef Pinquart M, Duberstein PR (2010) Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 75:122–137PubMedCrossRef
36.
Zurück zum Zitat Aarts MJ, Lemmens VE, Louwman MW, Kunst AE, Coebergh JW (2010) Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer 46:2681–2695PubMedCrossRef Aarts MJ, Lemmens VE, Louwman MW, Kunst AE, Coebergh JW (2010) Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer 46:2681–2695PubMedCrossRef
37.
Zurück zum Zitat Frederiksen BL, Osler M, Harling H, Ladelund S, Jorgensen T (2009) Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer? Soc Sci Med 69:1107–1115PubMedCrossRef Frederiksen BL, Osler M, Harling H, Ladelund S, Jorgensen T (2009) Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer? Soc Sci Med 69:1107–1115PubMedCrossRef
39.
Zurück zum Zitat Young JM, Leong DC, Armstrong K et al (2007) Concordance with national guidelines for colorectal cancer care in New South Wales: a population-based patterns of care study. Med J Aust 186:292–295PubMed Young JM, Leong DC, Armstrong K et al (2007) Concordance with national guidelines for colorectal cancer care in New South Wales: a population-based patterns of care study. Med J Aust 186:292–295PubMed
40.
Zurück zum Zitat Lee L, Cheung WY, Atkinson E, Krzyzanowska MK (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29:106–117PubMedCrossRef Lee L, Cheung WY, Atkinson E, Krzyzanowska MK (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29:106–117PubMedCrossRef
41.
Zurück zum Zitat Koroukian SM, Bakaki PM, Schluchter MD, Owusu C (2011) Treatment and survival patterns in relation to multimorbidity in patients with locoregional breast and colorectal cancer. J Geriatr Oncol 2:200–208PubMedCrossRef Koroukian SM, Bakaki PM, Schluchter MD, Owusu C (2011) Treatment and survival patterns in relation to multimorbidity in patients with locoregional breast and colorectal cancer. J Geriatr Oncol 2:200–208PubMedCrossRef
42.
Zurück zum Zitat Carmack CL, Basen-Engquist K, Gritz ER (2011) Survivors at higher risk for adverse late outcomes due to psychosocial and behavioral risk factors. Cancer Epidemiol Biomarkers Prev 20:2068–2077PubMedCrossRef Carmack CL, Basen-Engquist K, Gritz ER (2011) Survivors at higher risk for adverse late outcomes due to psychosocial and behavioral risk factors. Cancer Epidemiol Biomarkers Prev 20:2068–2077PubMedCrossRef
43.
Zurück zum Zitat Hawkes AL, Lynch BM, Youlden DR, Owen N, Aitken JF (2008) Health behaviors of Australian colorectal cancer survivors, compared with noncancer population controls. Support Care Cancer 16:1097–1104PubMedCrossRef Hawkes AL, Lynch BM, Youlden DR, Owen N, Aitken JF (2008) Health behaviors of Australian colorectal cancer survivors, compared with noncancer population controls. Support Care Cancer 16:1097–1104PubMedCrossRef
44.
Zurück zum Zitat Rock CL, Doyle C, Demark-Wahnefried W et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:242–274CrossRef Rock CL, Doyle C, Demark-Wahnefried W et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:242–274CrossRef
45.
Zurück zum Zitat Kosinski L, Habr-Gama A, Ludwig K, Perez R (2012) Shifting concepts in rectal cancer management. CA Cancer J Clin 62:173–202PubMedCrossRef Kosinski L, Habr-Gama A, Ludwig K, Perez R (2012) Shifting concepts in rectal cancer management. CA Cancer J Clin 62:173–202PubMedCrossRef
46.
Zurück zum Zitat Mell LK, Jeong J-H, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ (2010) Predictors of competing mortality in early breast cancer. Cancer 116:5365–5373PubMedCrossRef Mell LK, Jeong J-H, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ (2010) Predictors of competing mortality in early breast cancer. Cancer 116:5365–5373PubMedCrossRef
47.
Zurück zum Zitat German RR, Fink AK, Heron M et al (2011) The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 35:126–131PubMedCrossRef German RR, Fink AK, Heron M et al (2011) The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 35:126–131PubMedCrossRef
Metadaten
Titel
An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996–2009
verfasst von
Paramita Dasgupta
Danny R. Youlden
Peter D. Baade
Publikationsdatum
01.05.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0166-4

Weitere Artikel der Ausgabe 5/2013

Cancer Causes & Control 5/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.